Home›Companies›Biotech & Pharma›Ambrosia Biosciences

Ambrosia Biosciences Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 20, 2024·Suggest an edit

About Ambrosia Biosciences

Ambrosia Biosciences is a private company based in Boulder, Colorado, incorporated in 2024 in Delaware. It has reported $15,955,000 raised in one offering on Form D since August 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2024Aug 7, 2024amended Aug 20, 2024$15,955,000of $25.0M target7$2.2MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ambrosia Biosciences's Form D filed Aug 20, 2024.

DS
NT
Nicholas Traggis
Executive officer and director
Also a director at AEMS.
KL
Kyle Lefkoff
Director
JO
John Orwin
Director

Sources

  1. SECAmbrosia Biosciences Inc. Form D, filed Aug 7, 2024
  2. SECAmbrosia Biosciences Inc. filing history